Objective: Frontotemporal dementia (FTD) is a neurodegenerative disease that erodes uniquely human aspects of social behavior and emotion. The illness features a characteristic pattern of early injury to anterior cingulate and frontoinsular cortex. These regions, though often considered ancient in phylogeny, are the exclusive homes to the von Economo neuron (VEN), a large bipolar projection neuron found only in great apes and humans. Despite progress toward understanding the genetic and molecular bases of FTD, no class of selectively vulnerable neurons has been identified. Methods: Using unbiased stereology, we quantified anterior cingulate VENs and neighboring Layer 5 neurons in FTD (n ϭ 7), Alzheimer's disease (n ϭ 5), and age-matched nonneurological control subjects (n ϭ 7). Neuronal morphology and immunohistochemical staining patterns provided further information about VEN susceptibility. Results: FTD was associated with early, severe, and selective VEN losses, including a 74% reduction in VENs per section compared with control subjects. VEN dropout was not attributable to general neuronal loss and was seen across FTD pathological subtypes. Surviving VENs were often dysmorphic, with pathological tau protein accumulation in Pick's disease. In contrast, patients with Alzheimer's disease showed normal VEN counts and morphology despite extensive local neurofibrillary pathology. Interpretation: VEN loss links FTD to its signature regional pattern. The findings suggest a new framework for understanding how evolution may have rendered the human brain vulnerable to specific forms of degenerative illness.
Primate brain evolution has led to increasing frontal encephalization, hemispheric functional lateralization, and maturational delay. At the level of neuronal morphology, however, little differentiates humans from even our distant mammalian ancestors. Von Economo neurons (VENs) provide a notable exception. These large bipolar projection neurons are a unique feature of great apes and humans. 1 VENs display a simplified dendritic architecture 2 and form small clusters oriented perpendicularly to the brain surface. Paradoxically, VENs are restricted to brain regions often considered ancient in phylogeny, the anterior cingulate cortex (ACC) and frontoinsula (FI). 3, 4 Yet, VEN size and clustering increase with phyletic proximity to humans, 1 and VENs are far more abundant in humans than in apes. 5 VENs also mature late in development. In humans, they are identified mainly after birth and reach adult numbers by 4 years of age. 5 Across species, right hemisphere VENs outnumber those on the left, suggesting a role for these cells in social and emotional capacities that distinguish great apes and humans from other primates.
Frontotemporal dementia (FTD), a neurodegenerative condition with a mean onset in the sixth decade of life, 6 provides a potential intersection between brain evolution, VENs, and disease. FTD is as prevalent as Alzheimer's disease (AD) among dementia patients under age 65. 6 Some inherited forms of FTD feature pathological tau-positive neuronal cytoplasmic inclusions associated with mutations in the microtubule-associated protein tau, 7 whereas others have tau-negative, ubiquitin and TDP-43-positive inclusions (FTLD-U) due to mutations in progranulin. 8 -10 Yet, most cases of FTD, regardless of the aberrant protein, are sporadic. Across pathological subtypes, early symptoms in behavioral variant FTD reflect a loss of right-lateralized brain capacities that emerge late in childhood and are more robust in great apes and humans than in other primates. [11] [12] [13] So-cial and emotional self-awareness, moral reasoning, empathy, and "theory of mind" all deteriorate, 14 -19 with catastrophic effects on real-life social behavior. FTD deficits are accompanied by early, focal degeneration of the ACC and FI, often more severe in the nondominant hemisphere. 20 -24 The factors that determine this characteristic regional vulnerability pattern remain unknown. Furthermore, because the ACC and FI are classified as paralimbic cortices and are relatively well developed in distant mammals, it is surprising that FTD first affects recently evolved brain functions. Early, selective damage to VENs, however, would resolve this apparent contradiction and help to explain why FTD begins with ACC and FI degeneration.
To determine whether FTD is associated with selective and disease-specific VEN losses, we undertook a quantitative neuroanatomic study of the pregenual ACC (Fig 1) in FTD, AD, and nonneurological control (NNC) subjects.
Subjects and Methods

Subjects, Specimens, and Neuropathological Assessment
Archival brain tissues were contributed by the Institute for Brain Aging and Dementia and the University of California, Irvine (UCI) Alzheimer's Disease Research Center Tissue Resources. Seven NNCs, seven patients with FTD, and five patients with AD were studied. Demographic and autopsyrelated variables are shown in Supplementary Table 1 . NNC and AD groups were matched to the FTD group for age (one-way analysis of variance [ANOVA], F ϭ 0.912; p ϭ 0.422, not significant) and sex (Pearson's 2 ϭ 0.434; p ϭ 0.805, not significant). NNC subjects had no known neurological or psychiatric illness and no major structural pathology identified at autopsy. Although most FTD clinical information was recorded before publication of modern FTD research criteria, 25 symptoms described were typical of the FTD spectrum. All FTD subjects had prominent changes in social behavior and emotion, variably combined with deficits in language, memory, or executive function. None had clinical evidence of motor neuron disease or underwent electro- myography, and none had a first-degree relative with a FTDrelated illness. At autopsy, four had Pick's disease, and three had FTLD-U based on modern immunostaining techniques. 26 Patients with AD, in contrast, showed an array of cognitive symptoms, emphasizing visuospatial, memory, and language impairment, with relative sparing of social functions and behavior. All were clinically diagnosed with probable AD 26 during life and met pathological criteria for high likelihood AD. 27 Comorbid conditions that often accompany AD at autopsy were also found in our subjects: two had Lewy body pathology (diffuse neocortical type in one, transitional limbic in the other), two others had cerebrovascular disease (one had moderate-to-severe atherosclerosis with multiple small acute and remote microinfarcts in gray and white matter; the other had a small, remote intracranial hemorrhage in the left frontal white matter and mild cerebral amyloid angiopathy). No vascular lesion involved the ACC.
Brains were fixed in neutral buffered formalin after a brief postmortem interval (range, 2.5-8 hours) and prepared for evaluation using standard dementia diagnostic procedures.
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Pathological diagnoses were rendered at the source institution. At both UCI and UCSF, tissue blocks were sampled widely in dementia-relevant brain regions and stained with hematoxylin and eosin and modified Bielschowsky silver stains for initial review. Additional selected sections were stained as indicated for amyloid ␤ peptide, ␣-synuclein, hyperphosphorylated tau, and ubiquitin. The study was approved by the UCSF Committee on Human Research.
Disease Stage Assessment
For each patient with FTD, anatomic disease stage was assessed following a previously validated FTD rating scale (stages 0 -4: 0 ϭ normal and 4 ϭ most severe). 23 Photographs of coronal whole-brain 2-to 3cm slabs at the level of the temporal pole and lateral geniculate nucleus were examined by a neuropathologist (S.J.D.) blinded to all quantitative, clinical, and histopathological data. For three patients, only the anterior staging slab remained. Ratings indicated that a range of FTD disease stages was represented, including several patients with borderline or mild atrophy severity (see Supplementary Table 1) . If the anterior and posterior slabs differed in stage, subjects were rated according to the more severely affected slab. Anatomic stage and disease duration were at times discordant, perhaps due to difficulties identifying symptom onset or differing rates of progression across patients; tau-positive FTD is known to progress more slowly than tau-negative FTD. 28 In addition, we calculated the mean Layer 5 cross-sectional area from sections used to generate each subject's neuron counting data. This measure showed only a weak inverse correlation with disease stage (Spearman's , Ϫ0.15; p ϭ 0.37), perhaps because it fails to reflect change within an individual, but was used to provide a local index of atrophy severity and to confirm that apparent VEN selectivity was not a mere artifact of Layer 5 contraction. Clinical staging data for FTD subjects were not available. All AD patients required full-time care in the months preceding death and were Braak stage VI pathologically. 29 
Tissue Processing and Region-of-Interest Identification
Previous studies suggest that VENs are restricted to four brain regions, the ACC and FI of each hemisphere. 4, 30, 31 Because of tissue availability constraints, we evaluated the region most commonly intact in our subjects, the left ACC. Parts of this region had been dissected in each case for diagnostic purposes, precluding exhaustive ACC sampling. Therefore, we analyzed the pregenual ACC, which was intact in all subjects and provides reliable location for VEN sampling. 1, 31 Four-to 5mm-thick blocks were dissected at the level indicated in Figure 1 . The anterior surface was cut to intersect the corpus callosum as close as possible to 5mm posterior to the tip of the genu and perpendicular to the callosal and cingulate sulci to ensure that VENs fell maximally within the plane of section. Blocks were cryoprotected in successive 10, 20, and 30% sucrose solutions, frozen with dry ice on a freezing stage, and cut at 50m on a rotary microtome. Resulting sections, numbering 50 to 80 per subject, were Nissl-stained with cresyl violet at an interval of every fifth section and coverslipped. After drying, sections had a minimum thickness of 22m.
ACC tracings were performed, using Stereo Investigator software (MicroBrightField, Burlington, VT), by a single examiner (W.W.S.) at a microscope-computer interface attached to a motorized stage. First, the outline of the ACC was traced at low power (10ϫ magnification) beginning at the lateral recess of the callosal sulcus and ending at a line drawn directly from the recess of the cingulate sulcus to the white matter (see Fig 1) . Next, Layer 5 was outlined at higher magnification (40ϫ and 100ϫ), based on cell morphological details. 32 We chose Layer 5 as our region of interest (ROI) for neuron counting because VENs are located primarily in Layer 5b. 31 Although VENs can at times be found in Layer 6, we excluded this layer to avoid smaller, spindle-shaped cells or "fusiform" neurons found there more commonly. 1 Pilot data indicated that VENs were scarce in FTD. Therefore, securing reliable estimates required extensive counting within regions of maximum VEN density. For this reason, our Layer 5 ROI encompassed primarily areas 24a and 24b, which feature a much greater VEN density than area 24c. 31 Because the transition from 24b to 24c was at times difficult to discern in patients, we chose an anatomic boundary, ending the superior portion of the Layer 5 ROI at the point where the outer ACC curvature flattened (see Fig 1) . 32 
Neuron Quantification
VENs are thought to make up 1 to 2% of the Layer 5 neurons in ACC. 31 To assess VEN susceptibility, we estimated pregenual ACC VEN and Layer 5 neighboring neuron (NN) populations within the same ROI to afford a ratiometric analysis. This approach has two main advantages. First, tissue atrophy can increase cell density within an ROI, leading to overestimated neuronal integrity when the entire anatomic structure of interest cannot be evaluated. Cell ratios control for this source of error, because cell density increases as a function of ROI contraction, which applies uniformly to each cell type contained within the ROI. Second, the VEN/NN ratio provides an indicator of relative VEN loss, controlled within subjects for overall Layer 5 neuronal loss.
To implement this modified stereological approach, we counted on every fifth section from an arbitrary starting point, the first full-face section from each subject's tissue block. Pilot data indicated that, in control subjects, roughly five sections were needed to achieve reasonable coefficients of error (Յ 0.1, Schmitz-Hof equation 33 ) for the VENs. Therefore, we counted VENs and NNs in no less than five sections per subject, adding sections as needed to achieve a coefficient of error Յ 0.1. Because VEN counts in FTD patients were often so low, the coefficient of error after 10 sections was accepted if it remained greater than 0.1.
VENs and NNs were counted within the same Layer 5 ROI on separate runs of the optical fractionator. 34 
A single-point rule (nucleolus) ensured unbiased counting within the counting frame. Tissue atrophy can lead to denser packing of cells in patients. Although this confound should impact VEN and NN density equally, we considered whether VENs would be more difficult to identify in patients because of overlying glia or other neurons. To track VEN determinability, we designated a category for VEN-like cells not counted because of overlying cells that obscured VEN morphological inclusion criteria. The mean number of obscured VEN-like cells per section was similar across groups, slightly higher in NNC and AD than in FTD. Therefore, this potential confound would only have limited our ability to detect a selective VEN reduction in FTD.
Subjects from each diagnostic group were evenly distributed between two raters (D.A.C. and M.N.M.) who had completed a systematic training program. Once the experiment began, if a rater was uncertain about a cell's classification, this cell was marked for later review with the other rater. Though used sparingly, this method promoted consistency and periodic consensus building. The experiment began as a study of FTD and control subjects. FTD-related cellular changes can be appreciated on Nissl stains; therefore, raters could not be realistically blinded to whether a section was from a patient or control subject. After two control and three FTD subjects had been counted, newly available AD subjects were added. At this point, raters were formally blinded to information regarding diagnostic category. Raters were blinded to FTD anatomic stage and histopathological subtype throughout.
Interrater reliability was assessed by having each rater (independently) count every 15th section assessed by the other rater. For intrarater reliability, raters recounted their own N minus 15th section after every 15 sections, where N ϭ total sections counted by that rater throughout the experiment. For interrater reliability, VEN counts from the six sections showed an intraclass correlation coefficient (ICC) of 0.998 (95% confidence interval [CI], 0.993-1.000), and NN counts showed an ICC of 0.987 (95% CI, 0.906 -0.998). ICCs computed for intrarater reliability were high and similar for each rater. Combining data from the two raters to yield six sections, the intrarater ICC for VENs was 1.000 (95% CI, 0.987-1.000). For NNs, the ICC was 0.993 (95% CI, 0.949 -0.999).
Immunohistochemistry
The archival tissues used for neuron counting were largely inappropriate for immunohistochemical analysis. Therefore, paraffin-embedded 8m-thick ACC sections from banked UCSF Pick's and FTLD-U specimens (not included in the study) were examined for Bielschowsky silver, hyperphosphorylated tau (CP-13 antibody, gift of Peter Davies), and ubiquitin (polyclonal antibody; Dako North America, Carpinteria, CA) staining patterns. In addition, recently processed specimens from included AD subjects were reviewed for silver and tau staining characteristics.
Statistical Analyses
Primary analyses examined the effect of diagnostic group on VEN/section, NN/section, and VEN/10 4 NN counts. For these, we used one-way ANOVA and post hoc testing for pairwise group differences using Tukey's multiplecomparison method (alpha ϭ 0.05, two-tailed). Quantilequantile plots indicated that our measures were normally distributed within each diagnostic group, consistent with the assumptions of ANOVA. Supportive analyses assessed group differences in age and ACC/Layer 5 area, also using ANOVA with post hoc Tukey tests. Group differences in sex were assessed using Pearson's 2 analysis. Correlation between Layer 5 area, our indirect measure of disease stage, and VEN/10 4 NN was assessed using Pearson's correlation analysis (␣ ϭ 0.05, two-tailed) of the FTD group only (n ϭ 7). All statistical analyses were performed using SPSS 12.0 for Windows software (SPSS, Chicago, IL).
Results
Evidence for severe, selective, and early loss of VENs in FTD is shown in Figure 2 and Supplementary Table 2 . Compared with control subjects, patients with FTD showed a striking 74% reduction in VENs per section (see Fig 2A) . In contrast, and consistent with previous studies, 35 neighboring Layer 5 neurons showed only a mild reduction that was not statistically significant (see Fig. 2B ). We examined the degree of selective VEN loss by calculating the number of VENs per 10,000 NNs (VENs/10 4 NNs) for each subject. The FTD group showed a 69% reduction in VENs/10 4 NNs compared with control subjects (see Fig 2C) , indicating that VENs are exquisitely sensitive to the FTD degenerative process. Pick's disease, a tau-positive FTD subtype, and FTLD-U showed similar VEN dropout. Selective VEN losses were seen even in early-stage FTD and did not correlate with Layer 5 collapse (see Fig  2D) . These results suggest that VEN injury provides a key link between FTD and its signature pattern of anterior cingulate and frontoinsular vulnerability.
A previous study reported VEN loss in AD, 31 raising the possibility that VENs are susceptible to multiple forms of neurodegeneration. To address this issue, we studied five patients, age-matched to the FTD group, who were diagnosed with probable AD during life. All had pathological hallmarks of advanced AD. Nonetheless, absolute VEN counts in this group showed only mild, statistically nonsignificant reductions compared with control subjects (see Fig 2A; see Supplementary  Table 2 ). NN loss in AD was similar to that seen in FTD, resulting in a normal VEN/10 4 NN ratio in AD (see Figs 2B, C) . In contrast with the previous study, 31 our analysis used unbiased stereological probes, compared younger AD patients with a larger control group, and accounted for NN integrity. Our findings suggest that selective VEN loss is a defining feature of FTD but does not apply to AD. Patients with AD often show intact social graces until late in the illness despite widespread impairments in memory, language, and visuospatial cognition. In direct comparisons, FTD is distinguished from AD by loss of self-awareness, 14 empathy, 19 metacognitive judgment, 14 and behavioral control. 36 Further studies are needed to determine how these functional differences relate to VEN injury.
We found FTD-related changes in surviving VEN size, morphology, and immunohistochemical staining patterns that may provide clues to the mechanisms of VEN susceptibility. Surviving VENs in Pick's disease were often strikingly engorged, in some cases with small, ill-defined, hyperphosphorylated tau deposits littering their proximal dendrites or coalescing within the soma (Figs 3 and 4) . Tau supports microtubule stability and axonal transport, 37 and VENs, as large projection neurons, 2,31 may rely heavily on microtubules to deliver organelles, neurofilaments, or peroxisomes to the distal reaches of the cell. Spindle-shaped VEN somata may cope poorly with microtubule cargo backup, resulting in proximal cell distension and accelerated death. In contrast, despite severe VEN losses in FTLD-U, we have yet to observe significant VENassociated ubiquitin pathology. FTLD-U has recently been linked to null mutations in the gene for progranulin, a growth factor associated with cell proliferation and repair. 8, 9 Progranulin insufficiency or related mechanisms may be particularly deleterious to VENs, a late-developing neuronal population. 5 Twisting and corkscrewing of VEN dendrites were prominent in both FTD subgroups, especially in early stages (see Figs  3 and 4) . This feature was not encountered in patients with AD, in whom VENs exhibited normal morphology (see Fig 3) and appeared to rarely, if ever, form tangles despite dense neurofibrillary pathology in surrounding cortex (see Fig 4) . Because corkscrew morphology can occasionally be seen in control subjects, 4, 38 its relevance to cellular function or dysfunction remains uncertain. VEN clustering, a prominent feature only in chimpanzees and humans, 1 was rarely seen in FTD but was conspicuous in control subjects and AD. Proximity of VEN clusters to small arterioles (see Fig 1) may reflect high metabolic requirements that exacerbate oxidative VEN injury over the life span.
Discussion
VENs likely evolved 10 to 15 million years ago, 1 as an ancestor common to great apes and humans took on the neocortical machinery required for complex, agentoriented social cognition. VEN functions, however, remain unknown, as do the precise behavioral consequences of VEN injury. The ACC and FI represent anatomic transition zones between the paraolfactorylimbic allocortex and the frontotemporal neocortex. 40 As such, they sit poised to convey raw emotional data to top-down modulatory processors. Human VENs, as large, clustered projection neurons with sparse dendritic trees, may sample from a narrow range of inputs before sending a rapid output signal from the ACC and FI to other brain regions.
1,2 Although VEN projection targets are unknown and difficult to study, human functional magnetic resonance imaging connectivity maps reveal that ACC and FI activity levels correlate tightly with each other, 40, 41 with peripheral autonomic markers, 42 and with frontotemporal, limbic, and striatal sites 40 that support social cognition and recapitulate the broader FTD anatomic pattern. 22 Our findings support a new concept, that FTD is a disease of brain evolution in which degeneration occurs within an ancient, but recently VEN-enhanced, paralimbic behavioral guidance network.
Further characterization of VENs must move forward while respecting the small group of relevant species. In humans, the VEN somatodendritic compartment appears to express dopamine (D3), serotonin (5HT-1b, 2b), and vasopressin (1a) receptors. 5 VENs may enable these neurochemical systems to process reward, visceral-autonomic, and social-emotional bonding signals in a phylogenetically new way that is derailed in early FTD but spared in AD. In this light, therapies that enhance VEN neurotransmission may help ameliorate FTD symptoms. Basic studies are needed, however, to clarify how VEN biophysical and molecular properties promote VEN degeneration. In FTD, VEN-related dendritic atrophy, synaptic loss, and other markers of neuronal injury may precede frank neuronal dropout and offer an earlier window into disease pathogenesis. The findings of this study should be confirmed in larger series and extended to the frontal insula, where asymmetric VEN loss could relate to behavioral versus language FTD presentations.
Neurodegenerative diseases target specific brain regions and neuronal populations. 43 In FTD research, the finding of ACC and FI atrophy had gone unpaired with a vulnerable cell type. We found that both major FTD molecular subtypes target a recently evolved neuronal class, VENs, located only in the ACC and FI. Distinctive functions of these unique cells may prove invaluable in health, yet may also expose us to specific forms of developmental 5 or later-life illness. The link forged here between VENs and FTD should spawn further studies of how human brain evolution relates to human brain disease.
Note added in press
A recent study found VEN-like neurons in the ACC and FI of selected whale species, suggesting convergent evolution in large-brained socially complex mammals 
